Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Nanoparticle paves the way for new triple negative breast cancer drug

Professor Mohamed El-Tanani, Institute for Cancer Therapeutics, University of Bradford, UK.
CREDIT
University of Bradford
Professor Mohamed El-Tanani, Institute for Cancer Therapeutics, University of Bradford, UK. CREDIT University of Bradford

Abstract:
A potential new drug to tackle the highly aggressive 'triple negative' breast cancer - and a nanoparticle to deliver it directly into the cancer cells - have been developed by UK researchers.

Nanoparticle paves the way for new triple negative breast cancer drug

Bradford, UK | Posted on March 20th, 2017

The drug is a peptide (fragment of a protein) discovered by Professor Mohamed El-Tanani at the University of Bradford's Institute for Cancer Therapeutics. Professor El-Tanani has shown in computer models that the peptide blocks a protein called RAN which helps cancer cells to divide and grow. High levels of RAN have been linked to aggressive tumour growth, cancer spread, resistance to chemotherapy and poor prognosis in a number of cancers, including triple negative breast cancer (TNBC).

"We knew we'd need a novel delivery mechanism for this drug because peptides on their own are unstable and they can degrade too quickly to be effective," explains Professor El Tanani. "Using a nanoparticle as a delivery mechanism was the perfect solution."

Working with colleagues from Ulster University, Sunderland and Queen's University Belfast, the team developed a nanoparticle from a biodegradable polymer that could encapsulate the peptide. They tested various different polymers in order to determine which was most effective at helping the protein enter the cancer cells and attack them.

Laboratory tests showed that when this nanoparticle, loaded with the peptide, was added to the triple negative breast cancer cells, the cells would actively take it in. Their growth rate then reduced, they stopped replicating and around two thirds of the cells died within 24 hours. This compared with the peptide on its own, or an empty nanoparticle, which had no impact on the cells' growth.

The researchers also confirmed that the drug was killing the cancer cells through the mechanism they had seen in their computer models - by blocking the action of RAN which plays an important role in cell division and growth.

Previous research by Professor El-Tanani has shown that blocking RAN can also prevent or even reverse resistance to chemotherapy in small cell lung cancer.

Between 10-20 per cent of breast cancers are found to be triple negative - which means the cancer does not have receptors for the hormones oestrogen and progesterone or the protein HER2. This limits the range of treatments that can be used, resulting in poorer prognosis and increased risk of recurrence.

"By developing a nanoparticle that can help this peptide enter triple negative breast cancer cells and block RAN we've brought this potential new treatment a step closer to the clinic," said Professor El-Tanani. "We're already working on in vivo tests of the nanoparticle in a triple negative breast cancer model and are thinking ahead to taking this drug into clinical trials."

Professor El-Tanani is also working on a number of other potential RAN inhibitors, including a 'repurposed' drug that has been already pre-clinically validated in breast and lung cancer and is ready for clinical trials. The University of Bradford is actively seeking further funding and investor support to support the development of these drug candidates.

The findings are published in the International Journal of Pharmaceutics.

####

For more information, please click here

Contacts:
Mark Thompson

44-012-742-36510

Copyright © University of Bradford

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

RELATED JOURNAL ARTICLE:

Related News Press

News and information

Two-dimensional melting of hard spheres experimentally unravelled after 60 years: First definitive experimental evidence of two-dimensional melting of hard spheres April 21st, 2017

National Conference on Nanomaterials, (NCN-2017) April 21st, 2017

NanoMONITOR shares its latest developments concerning the NanoMONITOR Software and the Monitoring stations April 21st, 2017

Nanomechanics, Inc. Unveils New Product at ICMCTF Show April 25th: Nanoindentation experts will launch the new Gemini that measures the interaction of two objects that are sliding across each other – not merely making contact April 21st, 2017

Cancer

Nanopores could map small changes in DNA that signal big shifts in cancer April 13th, 2017

Keystone Nano Announces Start Of Clinical Testing Of Ceramide Nanoliposome For The Improved Treatment Of Cancer April 11th, 2017

New technology can detect tiny ovarian tumors: 'Synthetic biomarkers' could be used to diagnose ovarian cancer months earlier than now possible April 10th, 2017

Nanobiotix Expands its Clinical Development in Head and Neck Cancer and Immuno-Oncology New Clinical Data to be Presented at ASCO April 4th, 2017

Possible Futures

Two-dimensional melting of hard spheres experimentally unravelled after 60 years: First definitive experimental evidence of two-dimensional melting of hard spheres April 21st, 2017

Rice crew revved for Nanocar Race: Nanocar creator James Tour and team take on international competition with single-molecule marvel April 20th, 2017

Making Batteries From Waste Glass Bottles: UCR researchers are turning glass bottles into high performance lithium-ion batteries for electric vehicles and personal electronics April 19th, 2017

Better living through pressure: Functional nanomaterials made easy April 19th, 2017

Nanomedicine

Arrowhead Presents ARC-520 and ARC-521 Clinical Data at The International Liver Congress(TM) April 20th, 2017

Nano-SPEARs gently measure electrical signals in small animals: Rice University's tiny needles simplify data gathering to probe diseases, test drugs April 17th, 2017

Nanotubes that build themselves April 14th, 2017

Emergency Use Authorization for Gene-RADAR® Zika Virus Test: FDA Authorization for the Gene-RADAR® Zika Virus Test on the XPRIZE-Winning Gene-RADAR® Platform April 14th, 2017

Discoveries

Two-dimensional melting of hard spheres experimentally unravelled after 60 years: First definitive experimental evidence of two-dimensional melting of hard spheres April 21st, 2017

Wood filter removes toxic dye from water April 21st, 2017

Rice crew revved for Nanocar Race: Nanocar creator James Tour and team take on international competition with single-molecule marvel April 20th, 2017

Better living through pressure: Functional nanomaterials made easy April 19th, 2017

Announcements

Two-dimensional melting of hard spheres experimentally unravelled after 60 years: First definitive experimental evidence of two-dimensional melting of hard spheres April 21st, 2017

National Conference on Nanomaterials, (NCN-2017) April 21st, 2017

NanoMONITOR shares its latest developments concerning the NanoMONITOR Software and the Monitoring stations April 21st, 2017

Nanomechanics, Inc. Unveils New Product at ICMCTF Show April 25th: Nanoindentation experts will launch the new Gemini that measures the interaction of two objects that are sliding across each other – not merely making contact April 21st, 2017

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers

Two-dimensional melting of hard spheres experimentally unravelled after 60 years: First definitive experimental evidence of two-dimensional melting of hard spheres April 21st, 2017

Wood filter removes toxic dye from water April 21st, 2017

Making Batteries From Waste Glass Bottles: UCR researchers are turning glass bottles into high performance lithium-ion batteries for electric vehicles and personal electronics April 19th, 2017

Better living through pressure: Functional nanomaterials made easy April 19th, 2017

Nanobiotechnology

Arrowhead Presents ARC-520 and ARC-521 Clinical Data at The International Liver Congress(TM) April 20th, 2017

Nano-SPEARs gently measure electrical signals in small animals: Rice University's tiny needles simplify data gathering to probe diseases, test drugs April 17th, 2017

Nanotubes that build themselves April 14th, 2017

Emergency Use Authorization for Gene-RADAR® Zika Virus Test: FDA Authorization for the Gene-RADAR® Zika Virus Test on the XPRIZE-Winning Gene-RADAR® Platform April 14th, 2017

Research partnerships

Better living through pressure: Functional nanomaterials made easy April 19th, 2017

Shedding light on the absorption of light by titanium dioxide April 14th, 2017

AIM Photonics Presents Cutting-Edge Integrated Photonics Technology Developments to Packed House at OFC 2017, the Optical Networking and Communication Conference & Exhibition April 11th, 2017

Nanoparticles open new window for biological imaging: “Quantum dots” that emit infrared light enable highly detailed images of internal body structures April 10th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project